A Clinical and Pharmacoeconomic Justification for Intravenous Acetylcysteine: A US Perspective

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.24, Iss.2, 2005-01, pp. : 131-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous acetylcysteine for the treatment of acetaminophen overdose

By Klein-Schwartz Wendy Doyon Suzanne

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 119-130

Informa Healthcare

Access to resources Recommend Favorite

The Perspective of a Pharmacoeconomic Study: Targeting for Audiences

By Szucs T.D. Mantovani L.G.

Pharmacological Research, Vol. 35, Iss. 5, 1997-05 ,pp. : 471-475

Academic Press

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Intravenous Push vs Slow Infusion of -Lactam Antibiotics

By Ambrose P.G.

Clinical Drug Investigation, Vol. 17, Iss. 5, 1999-05 ,pp. : 407-410

Adis International

Access to resources Recommend Favorite

The US FDA has approved acetadote [acetylcysteine] labelling updates

Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding

By Keating Gillian M.

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 535-543

Adis International

Access to resources Recommend Favorite